IMFINZI study in patients with extensive stage small cell lung cancer

Trial Identifier:	D419QC00006
Sponsor:	AstraZeneca
NCTID::	NCT04854590
Start Date:	April 2021
Primary Completion Date:	July 2023
Study Completion Date:	July 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.